Do you have at least 7 years clinical development experience in neurodegeneration including at least one role in SMID biotechs?

Do you have prior experience with ALS?

Do you have an advanced degree (e.g., MD, PhD, PharmD) or equivalent?

Do you have a proven record of successful design, execution, close out and reporting of Phase 2 and 3 clinical trials?

Do you have deep understanding of clinical trial design, execution, and regulatory requirements, particularly in rare disease areas?

Do you have established links with the medical community globally and locally, with proven ability to develop close working relationships with KOLs?

Do you have a proven track record of successfully leading late-stage clinical development programs including rare indications through regulatory approval?

Do you have broad working knowledge of industry compliance requirements in US and EU, clinical trial design and strategies, and medical information process?